Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-β and fibronectin, and lipid peroxidation induced by high glucose in cultured mesangial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1457-1462

  Ha, Hunjoo ^a   Lee, Sang H ^a   Kim, K Hwan ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; REBAMIPIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG BLOOD LEVEL; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMUNOBLOTTING; KIDNEY DISEASE; LIPID PEROXIDATION; MALE; MESANGIUM CELL; MICROALBUMINURIA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

ALANINE; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; FIBRONECTINS; GLUCOSE; LIPID METABOLISM; MALE; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030972189     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. AYO, S. H., RADNIK, R. A., GARONI. J., GLASS II, W. F. AND KREISBERG, J. I.: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am. J. Pathol. 136: 1339-1348, 1990.
2. AYO, S. H., RADNIK, R. A., GLASS II, W. F., GARONI, J., RAMPT, E. R., APPLING, D. R. AND KREISBERG, J. I.: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high glucose medium. Am. J. Physiol. 260: F185-F191, 1991.
3. BAYNES, J. W.: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
4. BRADFORD, M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
5. CHOMCZYNSKI, P. AND SACCHI, N.: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
6. Fox, R. B.: Prevention of granulocyte-mediated oxidant lung injury in rats by a hydroxyl radical scavenger, dimethylthiourea. J. Clin. Invest. 74: 1456-1464, 1984.
7. HA H., TOJO A. AND ENDOU H.: Proximal tubular dysfunction as a cause of diabetic microalbuminuria. Physiologist 34: 249, 1991 (Abstract).
8. HA, H., KIM, C., SON, Y., CHUNG, M. H. AND KIM, K. H.: DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria. Free Radical Biol. Med. 16: 271-274, 1994.
9. HA, H., YOON, S. J. AND KIM, K. H.: High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int. 46: 1620-1626. 1994.
10. HA, H., LEE, S. H. AND KIM, K. H.: Involvement of oxidative stress associated with high glucose in transforming growth factor-β and fibronectin production. J. Am. Soc. Nephrol. 7: A3117, 1996 (Abstract).
11. HALLIWELL, B., GUTTERIDGE, J. M. AND CROSS, C. E.: Free radicals, antioxidants and human diseases: Where are we now? J. Lab. Clin. Med. 119: 598-620, 1992.
12. 1c by a new liquid Chromatographie assay. Methodology, clinical utility, and relation to glucose tolerance evaluated. Clin. Chem. 32: 1867-1872, 1986.
13. KIM, C. D. AND HONG, K. W.: Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat. J. Pharmacol. Exp. Ther. 275: 340-344, 1995.
14. LARKINS, R. G. AND DUNLOP, M. E.: The link between hyperglycemia and diabetic nephropathy. Diabetologia 35: 499-504, 1992.
15. LEE, S. M. AND KIM, K. H.: Rebamipide ameliorates hepatic dysfunction induced by ischemia/reperfusion in rats. Eur. J. Pharmacol. 294: 41-46, 1995.
16. MAUER, S. M., STEFFES, M. W., ELLIS, E. N., SUTHERLAND, D. E. R., BROWN, D. M. AND GOETZ, F. C.: Structural functional relationships in diabetic nephropathy. J. Clin. Invest. 74: 1143-1155, 1984.
17. MEYEROVITCH, J., FARFEL, Z., SACK, J. AND SCHECHTER, Y.: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J. Biol. Chem. 262: 6658-6662, 1987.
18. MOGENSEN C. E.: Natural history of renal functional abnormalities in human diabetes mellitus: from normoalbuminuria to incipient and overt nephropathy. In The Kidney in Diabetes Mellitus, ed. by B. M. Brenner and J. H. Stein, pp. 19-49, Churchill Livingstone, New York, NY, 1989.
19. OHKAWA, H., OHISHI, N. AND YAGI, K.: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358, 1979.
20. PIECHACZYK, M., BLANCHARD, J. M., MARTY, L., DANI. CH., PANABIERES, F., EI. SABOUTY, S., FORT, PH. AND JEANTEUR, PH.: Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acid Res. 12: 6951-6963, 1984.
21. THE DIABETES CONTROL AND COMPLICATIONS TRIAL RESEARCH GROUP: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
22. TRACHTMAN, H., FUTTERWEIT, S. AND BIENKOWSKI, R. S.: Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 191: 759-765, 1993.
23. TRACHTMAN, H.: Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvasc. Res. 47: 232-239, 1994.
24. TRACHTMAN, H., FUTTERWEIT, S., MAESAKA J., MA. C., VALDERRAMA, E., FUCHS, A., TARECTECAN, A. A., RAO, P., STURMAN, J. A., BOLES, T. H., FU, M. AND BAYNES, J.: Taurine ameliorates chronic streptozotocin-induced diabetic nephropathy in rats. Am. J. Physiol. 269: F429-F438, 1995.
25. TSANG, V. C. W., PERALTA, J. M. AND SIMONS, A. R.: Enzyme-linked immunoelectrotransfer blot technique for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol. 92: 377-391, 1983.
26. VIBERTI, G. C., HILL, R. D., JARRETT. R. J., ARGYROPOULOS, A., MAHMUD, U. AND KEEN, H.: Microalbuminuria as a predictor of clinical nephropahty in insulin-dependent diabetes mellitus. Lancet 1: 1430-1432, 1982.
27. WOLF, G., SHARMA, K., CHEN, Y., ERICKSEN, M. AND ZIYADEH, F. N.: High glucoseinduced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int. 42: 627-656, 1992.
28. WOLFF, S. P., JIANG, Z. Y. AND HUNT, J. V.: Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radical Biol. Med. 10: 339-352, 1991
29. WOLFF, S. P.: Diabetes mellitus and free radicals. Br. Mud. Bull. 49: 642-652, 1993.
30. YOSHIKAWA, T., NAITO, Y., TANIGAWA, T. AND KONDO, M.: Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittel-Forschung 43: 363-366, 1993.
31. ZIYADEH, F. N. AND SHARMA, K.: Role of transforming growth factor-β in diabetic glomerulosclerosis and renal hypertrophy. Kidney Int. 48(Suppl. 51): S34-S36, 1995.